Oat Beta‑Glucan Powder 70% (1,3/1,4‑β‑D‑Glucan): Molecular Characteristics & Global Regulatory Status of Cereal‑Derived Soluble Fibre

I. Unique Molecular Architecture of Mixed‑Linkage Oat Beta‑Glucan

Oat beta‑glucan is a linear soluble Polysaccharide extracted from oat endosperm cell walls, chemically defined as mixed‑linkage (1,3/1,4)‑β‑D‑glucan. Its glucose repeating units are predominantly connected by β‑1,4 glycosidic bonds, intermittently interrupted by β‑1,3 linkages. This special mixed‑linkage structure determines its hydration property, solution viscosity and overall functional behaviour, and fundamentally differentiates cereal‑sourced oat beta‑glucan from yeast‑origin beta‑glucan which features β‑1,3/1,6 branching patterns. Even with identical 70% assay specification, differences in molecular‑weight distribution will cause obvious deviation in viscosity and practical performance in downstream products, an observation repeatedly documented in open‑access PMC academic reviews focused on cereal polysaccharides. Formulators should pay attention to molecular‑weight profile beyond simple assay value when evaluating raw‑material batches.

II. Global Regulatory Evaluation for 70% Oat Beta‑Glucan

The 70‑percent specification of oat beta‑glucan exactly matches the quality indicator from China’s Novel‑Food Raw Material Announcement (2014‑No.20). Under domestic regulation, permitted application scope and maximum daily intake of 5 g per person are clearly defined for food manufacturing. In European market, EFSA has released successive scientific assessments targeting oat‑derived mixed‑linkage 1,3/1,4‑β‑D‑glucan. Its 2026 scientific opinion validates the condition‑dependent relationship between oat beta‑glucan intake and reduced postprandial glucose peak, specifying dosage and food‑matrix prerequisites for eligible health‑claim use. Earlier EFSA publications further reviewed physiological responses related to cholesterol metabolism. Meanwhile, FDA recognises the qualified‑health‑claim condition for oat soluble fibre regarding coronary‑heart‑disease risk reduction. It is worth emphasising that identical raw material cannot directly copy‑paste health‑claim wording across territories. Every region enforces strict preconditions on dosage, serving matrix and labelling text. Manufacturers need to align finished‑product labelling with local regulatory frameworks even when using qualified bulk ingredients. Multilateral scientific‑consensus documents summarise these cross‑border evaluation outcomes for industry reference.

III. Sourcing Note

We supply bulk Oat Beta‑Glucan Powder 70% (1,3/1,4‑D‑Glucan). Relevant documentation including COA is available. You may reach out for sample request, quotation and procurement‑related support.